New User Special Price Expires in

Let's log you in.

Sign in with Facebook


Don't have a StudySoup account? Create one here!


Create a StudySoup account

Be part of our community, it's free to join!

Sign up with Facebook


Create your account
By creating an account you agree to StudySoup's terms and conditions and privacy policy

Already have a StudySoup account? Login here

L#21 & #22: Autoimmunity and Cancer and Transplant Immunology

by: Denise Croote

L#21 & #22: Autoimmunity and Cancer and Transplant Immunology 0530

Marketplace > Brown University > Biology > 0530 > L 21 22 Autoimmunity and Cancer and Transplant Immunology
Denise Croote
Brown U
GPA 3.9

Preview These Notes for FREE

Get a free preview of these Notes, just enter your email below.

Unlock Preview
Unlock Preview

Preview these materials now for free

Why put in your email? Get access to more of this material and other relevant free materials for your school

View Preview

About this Document

The lecture on autoimmunity covers the causes and treatments for autoimmunity and the common autoimmune diseases. The Cancer and Transplant immunology lecture covers the characteristics of cancer, ...
Principles of Immunology
Dr. Richard Bungiro
Class Notes
autoimmunity, cancer, transplant, immunology
25 ?




Popular in Principles of Immunology

Popular in Biology

This 4 page Class Notes was uploaded by Denise Croote on Saturday January 23, 2016. The Class Notes belongs to 0530 at Brown University taught by Dr. Richard Bungiro in Fall 2013. Since its upload, it has received 23 views. For similar materials see Principles of Immunology in Biology at Brown University.

Similar to 0530 at Brown U


Reviews for L#21 & #22: Autoimmunity and Cancer and Transplant Immunology


Report this Material


What is Karma?


Karma is the currency of StudySoup.

You can buy or earn more Karma at anytime and redeem it for class notes, study guides, flashcards, and more!

Date Created: 01/23/16
Lecture Twenty One: Autoimmunity  An attack on self that results from failure to distinguish between self and non-self  Mediated by auto-antibodies or self reactive T cells  Tolerance is a state of non-responsiveness to a self antigens  Toleragens are antigens that induce tolerance  Factors that promote Tolerance: o High Ag dose o Ag persistence o Absence of adjuvants o Lack of inflammatory stimuli o Low levels of co-stimulation  Central tolerance is where self reactive B cells are deleted in the bone marrow and self reactive T cells are deleted in the thymus  Peripheral tolerance is where self reactive B cells are anergized or deleted and is usually mediated by T regulatory cells  Sequestration is a non tolerogenic mechanism by which certain antigens are isolated in tissues, prevent contact with lymphocytes  Experiments have shown that B cells reactive to self antigen will either be deleted or undergo receptor editing, introducing anti-self antigen into the periphery induces anergy  T Regulatory Cells o Selected in the thymus for their intermediate affinity o 5-7% of the CD4 T cells in the periphery o Suppressive mechanism is unknown but shown to involve CTLA4 and IL10 o Pathogens may induce T regs as a survival strategy  Autoimmune responses can directly cause cell death or damage via antibodies (ADCC or C’ activation) or cell mediated (DTH or CTLs)  Autoimmunity can lead to the production of auto-antibodies which can act on hormone receptors and either mimic the actions of the hormones and stimulate the receptor or block the receptor and antagonize the actions on the hormones  Diseases are most common in 40 -60 year old women, it could be because damages have accumulated all of their life or it could be because of the hormone changes that occur around this time  COMMON DISEASES: o Hashimoto’s Thyroiditis – autoantibodies and Th1 cells go after thyroid proteins and cause inflammation and hypothyroidism o Pernicious Anemia – autoantibodies block vitamin B uptake interfering with RBC production o Hemolytic Anemia – autoantibodies to RBC or drugs that bind to RBCs induce phagocytosis or C’ activation o Goodpasture’s Syndrome – autoantibodies bind to membranes in kidney and lungs leading to inflammation, IgG completely saturates kidney secretions o Insulin Dependent Diabetes - autoantibodies and Th1 cells mediated the destruction of insulin producing beta cells resulting in unregulated blood sugar levels o Grave’s Disease – autoantibodies bind to TSH receptor on thyroid and stimulate is causing overproduction of thyroid hormones (hyperthyroisism) o Myasthenia Gravis – autoantibodies to Ach block Ach binding to activate muscles resulting in weakness and fatigue o Systemic Lupus – autoantibodies against DNA, histones, RBCs, platelets, clotting factors leads to immune complexes and complement activation o Multiple Sclerosis – autoreactive T cells mediate inflammatory lesions along the myelin sheaths of nerves causing neurological damages, weakness, and paralysis, scraping off the insulation of the nerves makes it difficult for them to fire o Rheumatoid Arthritis – autoantibodies bind to IgG to form immune complexes that deposit in the joints and activate complement  Factors thought to induce Autoimmunity o CD4 T cells o Certain MHC alleles are more common among individuals with autoimmune diseases o Certain TCR variable regions are more common in mice with autoimmunity  What can cause autoimmunity? o Failure of tolerance promoting mechanisms to develop like….  Fas mutations decreasing apoptosis  AIRE mutations decreasing central tolerance  Foxp3 mutations decreasing Tregs o Release of sequestered Ags due to injury or infection o Cytokine imbalances o Molecular mimicry – certain epitopes on pathogens can be found elsewhere in the body  How to treat autoimmunity? o Most therapies are aimed at replacing the damages organ o Use of immunosuppressive drugs o Remove the autoantibodies from the blood, but this is only temporary because they will regenerate o New experimental approaches: antibodies directed against the MHC, TCR, CD4 o Introducing a worm infection to increase the Th2 response so that the Th1 (autoimmune) response decreases Lecture Twenty Two: Cancer Immunology  Characteristics of a Cancer Cell o Provide their own growth signals o Avoid cell death o Ignore growth inhibitory signals and replicate without limits o Produce their own new blood vessels to sustain growth  Immuno-surveillance theory states that the immune systems is able to recognize and eliminate malignant cells and cancer develops when these malignant cells can circumvent the immune response  Immunodeficient mice (lacking perforin for lysis for example) and immunodeficient humans have an increased risk of cancer  Some tumors develop as a result of infectious pathogens, for example leukemia can be caused by Epstein Barr virus  Some tumors develop as a result of inflammation, for example Hepatitis B infection can lead to hepatocellular carcinoma  During apoptosis cells move phosphotidylseme from the inside of the cell to the outside of the cell, which serves as a “I’m dying come eat me signal”  Tumors can subvert the Immune Response by: o Cancer cells are often very close to self cells and their difference could go unnoticed, resulting in tolerogenic cell activation o Tumors create their own special blood vessels and T cells are unable to leave the circulation to attack the infected cell o Cancer cells can inhibit T cells  Express inhibitory ligands for T cells  Cancer contains cells that inhibit T cells (like T regs) on contact and with cytokines  Have factors that inhibit T cell function (like inhibiting granzyme formation so that granzymes can’t lyse the tumor cells)  How do you activate the immune response to fight the cancer? o Give antibodies that block inhibitory receptor signals o Give antibodies that induce activation of T cells o Give antibodies that deplete T regs o Activate the patients lymphocytes outside the body and infuse the activated cells back into the body o Infuse lymphocytes from other individuals o Apply inflammatory mediators to return the blood vessels to normal so that the T cells can exit the circulation and attack the cancerous area  Cancer Vaccines – the best vaccine would have to be specific to an antigen that is expressed on the tumor cell and not in other tissues and that is important to the growth and development of the tumor o Possible antigens:  Tumor Associated Proteins: normal proteins that are hugely over-expressed in the tumor cells but are also expressed in other tissues at certain stages of differentiation  Tumor Specific Antigens: antigens only expressed in the tumor or mutated self proteins  Tumor cells have lots of variation, killing just some of the cells won’t do any good, need to kill the cells with proteins that have been universally up-regulated on the cells  Methods of vaccination o Directly inject a apoptotic tumor cell o Inject isolated tumor antigens o Inject peptides that have shown to be presented by HLA antigens expressed by the patient o Injection of antigens usually requires co-injection of adjuvants to get a response  Vaccinations is not very successful because by that point the cancer has usually already caused a substantial amount of damage  Process of Adoptive Cell Transfer involves taking a patient’s dendritic cells, expanding them in vitro with cytokines, loading them with antigens, and injecting them back into the patient (limited success)  New attempts to transfer immune cells: o Lymphokine activated killer cells (LAK) – cells that are able to kill a wide range of tumor targets. The only problem is that they require high levels of IL2 stimulation in vivo and high levels of IL2 can cause capillary leakage o Tumor infiltration lymphocytes (TIL) – these take the tumor tissue and dissociate it o Cancer specific T cells are better at expanding in vitro than in vivo  Chimeric Antigen Receptors – collect patient T cells and insert CAR into all of the T cells. CAR is a tumor antigen specific antibody variable region with a CD3 signaling domain. When injected into the patient, antibody portion of CAR binds tumor antigen and CD3 signals the T cell to activate Transplant Immunology  Vocabulary o Autologous – from the same individual o Syngeneic – from another member of the same inbred strain o Allogeneic – from a different strain or individual of the SAME species o Xenogeneic – from a different species  Strong T cell response to allogeneic MHC and HLA disparities causes transplant rejections  To treat, a patient is given a high dose of chemotherapy/radiation to eliminate the tumor cells and then injected with a source of HSC cells to restablish the HSC system o Commonly injected with bone marrow, mobilized peripheral blood mononuclear cells, or cord blood o Graft vs. Host Disease is when allogeneic T lymphocytes present in the stem cells of the donor begin to attack the host. Is significant of a decreased graft vs tumor (GVT) relapse rate. o Cellular immunotherapy involves infusing a large number of haploidentical WBCs into the patient with the tumor, results in a rapid elimination of the donor cells  Types of Rejection responses o Hyperacute – rejection occurs within minutes and is caused by preformed antibodies o Acute – rejection occurs within days or weeks and is caused by cellular immune responses o Chronic – rejection occurs over months or years and is caused by fibroblasts and increased collagen production  Triggers for Transplant Rejection: o Disparity at HLA antigens – alloreactivity (MHC) o Disparity at non HLA antigens  Minor Histocompatibility antigens – cytoplasmic proteins with different alleles coding for amino acid polymorphisms that can be recognized as foreign. Peptides from these proteins are presented by MHC molecules and trigger responses when stimulating cells from another individual o Immunological History of the recipient/donor  Presence of antibodies and anticarbohydrates from other infections  Presence of anti-HLA alloantibodies from pregnancy, transplant, or other infusions  The presence of these preformed antibodies can trigger hyperrejection  T cell responses to viruses in the past can increase alloreactivity  Tolerance induction has worked in mice but is harder to induce in humans because we all have different histories and will react to the transplant differently  Whether or not the patient in on immunosuppressive drugs can affect transplant rejection  The balance of donor to recipient cells also affects the amount of rejection o Surgeon damage – damage signals are released when the surgeon makes the incisions and damages the tissue around the transplant area, level of damage can affect how much the immune response is triggered  Ways to overcome transplant rejection(blocking the immune response) o Inhibit lymphocyte proliferation with mitotic inhibitors o Inhibit costimulation by blocking CD28 function and CD40 function (CTLA4 can do this) o Inducing immunoregulatory cells (like Tregs )  Summary: o With cancer you DON’T want to suppress the immune system because then the cancer will grow o With transplant you WANT to suppress the immune system so rejection will not occur  With HSC transplants you worry about the DONOR attacking the HOST  With organ transplants you worry about the HOST attacking the DONOR 


Buy Material

Are you sure you want to buy this material for

25 Karma

Buy Material

BOOM! Enjoy Your Free Notes!

We've added these Notes to your profile, click here to view them now.


You're already Subscribed!

Looks like you've already subscribed to StudySoup, you won't need to purchase another subscription to get this material. To access this material simply click 'View Full Document'

Why people love StudySoup

Bentley McCaw University of Florida

"I was shooting for a perfect 4.0 GPA this semester. Having StudySoup as a study aid was critical to helping me achieve my goal...and I nailed it!"

Kyle Maynard Purdue

"When you're taking detailed notes and trying to help everyone else out in the class, it really helps you learn and understand the I made $280 on my first study guide!"

Steve Martinelli UC Los Angeles

"There's no way I would have passed my Organic Chemistry class this semester without the notes and study guides I got from StudySoup."


"Their 'Elite Notetakers' are making over $1,200/month in sales by creating high quality content that helps their classmates in a time of need."

Become an Elite Notetaker and start selling your notes online!

Refund Policy


All subscriptions to StudySoup are paid in full at the time of subscribing. To change your credit card information or to cancel your subscription, go to "Edit Settings". All credit card information will be available there. If you should decide to cancel your subscription, it will continue to be valid until the next payment period, as all payments for the current period were made in advance. For special circumstances, please email


StudySoup has more than 1 million course-specific study resources to help students study smarter. If you’re having trouble finding what you’re looking for, our customer support team can help you find what you need! Feel free to contact them here:

Recurring Subscriptions: If you have canceled your recurring subscription on the day of renewal and have not downloaded any documents, you may request a refund by submitting an email to

Satisfaction Guarantee: If you’re not satisfied with your subscription, you can contact us for further help. Contact must be made within 3 business days of your subscription purchase and your refund request will be subject for review.

Please Note: Refunds can never be provided more than 30 days after the initial purchase date regardless of your activity on the site.